1. 387368dman
2. kitcaitrn
3. jeepmagick
4. matthewsmelt6
5. jil4411
1.jeepmagick 06/18/2018
Good reason to feel good.
2.387368dman 02/12/2018
Cantor Fitzgerald raises price target to $5 from $2
3.matthewsmelt6 06/18/2018
Arrowhead Pharmaceuticals (ARWR): Speedy ARO-AAT Enrollment Signals Catalysts to Come, Says Cantor
4.kitcaitrn 02/09/2018
Misses EPS loss estimates by $0.02 and misses on revenues
5.387368dman 02/22/2018
Receives regulatory clearance to begin Phase 1 Study of ARO-AAT for treatment of Alpha-1 Liver disease
6.jil4411 06/29/2018
Arrowhead Presents New Clinical Data on ARO-AAT at Alpha-1 National Education Conference
7.matthewsmelt6 03/27/2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
8.jeepmagick 02/15/2018
Receives regulatory clearance to begin Phase 1/2 study of ARO=HBV for treatment of Hepatitis B
9.387368dman 05/21/2018
Presents new data on ARO-ENaC
10.kitcaitrn 02/15/2018
Granted orphan drug designation
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW